LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
Yükleniyor...
Dosyalar
Tarih
2018-09-06
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
NATURE PUBLISHING GROUP
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other.
Açıklama
Anahtar Kelimeler
LYSYL OXIDASE, TUMOR ANGIOGENESIS, DRUG-DELIVERY, DOUBLE-BLIND, PHASE-II, DOXORUBICIN, IMPROVES, COMBINATION, SIMTUZUMAB, INHIBITION
Kaynak
ONCOGENE
WoS Q Değeri
Q1
